U

Aion Therapeutic Inc. ANTCF

$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Aion Therapeutic Inc. (AION) is referenced in public records as a privately held biotechnology company, but detailed, independently verifiable information regarding its operations, products, or commercialization activities is limited. Based on available public disclosures, the company does not appear to have filed public registration statements or periodic reports with the U.S. Securities and Exchange Commission (SEC), indicating it is not a publicly listed issuer. As a result, its precise industry focus, revenue model, and competitive positioning cannot be fully confirmed from authoritative financial or regulatory sources.

Available information suggests that Aion Therapeutic Inc. operates within the biopharmaceutical or therapeutic research sector, potentially at an early or pre-commercial stage. However, specific details regarding therapeutic areas, clinical programs, or proprietary technologies are data inconclusive based on available public sources, and no independently verified corporate history or evolution timeline is publicly documented.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Tuesday, April 1, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
(est)

Price History

Loading...
52-Week Range2% of range
Low
$0.00
Current
$0.00
High
$0.02
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Website
--
Phone Number
416 460 3000
Address
700 West Georgia Street
Suite 2200
Vancouver, BC V7Y 1K8
Country
Year Founded

Headlines

There are no news to display.